Skip to main content
Matthew A. Szaniawski
No Rating Available
(Learn About Our Rating System)

Matthew A. Szaniawski, MD, PhD, MSCI

Languages spoken: English

Clinical Locations

Primary Children's Hospital

Pediatric Hospital Medicine
Salt Lake City
801-662-1000
  • Board Certification and Academic Information

    Academic Departments Pediatrics -Visiting Instructor
    Academic Divisions Hospital Medicine

    Education history

    Residency Medicine - University of Utah Spencer Fox Eccles School of Medicine Resident
    Professional Medical Medicine - University of Utah School of Medicine M.D.
    Graduate Training Howard Hughes Medical Institute/Molecular Med-to-Grad Program - University of Utah School of Medicine M.S.C.I
    Graduate Training Microbiology and Immunology - University of Utah School of Medicine Ph.D.
    Undergraduate Medical Microbiology and Immunology - University of Wisconsin-Madison B.S.

    Selected Publications

    Journal Article

    1. Lim AL, Moos P, Pond CD, Larson EC, Martins LJ, Szaniawski MA, Planelles V, Barrows LR (2022). HIV-1 provirus transcription and translation in macrophages differs from pre-integrated cDNA complexes and requires E2F transcriptional programs. Virulence, 13(1), 386-413. (Read full article)
    2. Martins LJ, Szaniawski MA, Williams ESCP, Coiras M, Hanley TM, Planelles V (2022). HIV-1 Accessory Proteins Impart a Modest Interferon Response and Upregulate Cell Cycle-Related Genes in Macrophages. Pathogens, 11(2). (Read full article)
    3. Williams ESCP, Szaniawski MA, Martins LJ, Innis EA, Alcam J, Hanley TM, Spivak AM, Coiras M, Planelles V (2022). Dasatinib: effects on the macrophage phospho proteome with a focus on SAMHD1 and HIV-1 infection. Clin Res HIV AIDS, 8(1). (Read full article)
    4. Innis EA, Levinger C, Szaniawski MA, Williams ESCP, Alcam J, Bosque A, Schiffer JT, Coiras M, Spivak AM, Planelles V (2021). Pharmacologic control of homeostatic and antigen-driven proliferation to target HIV-1 persistence. Biochem Pharmacol, 194, 114816. (Read full article)
    5. Schynkel T, Szaniawski MA, Spivak AM, Bosque A, Planelles V, Vandekerckhove L, Trypsteen W (2020). Interferon-Mediated Long Non-Coding RNA Response in Macrophages in the Context of HIV. Int J Mol Sci, 21(20). (Read full article)
    6. Szaniawski MA, Spivak AM (2019). Recurrent Paenibacillus infection. Oxf Med Case Reports, 2019(5), omz034. (Read full article)
    7. Szaniawski MA, Spivak AM, Bosque A, Planelles V (2018). Sex Influences SAMHD1 Activity and Susceptibility to Human Immunodeficiency Virus-1 in Primary Human Macrophages. J Infect Dis, 219(5), 777-785. (Read full article)
    8. Macedo AB, Resop RS, Martins LJ, Szaniawski MA, Sorensen ES, Spivak AM, Nixon DF, Jones RB, Planelles V, Bosque A (2018). Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus. AIDS Res Hum Retroviruses, 34(9), 769-777. (Read full article)
    9. Szaniawski MA, Spivak AM, Cox JE, Catrow JL, Hanley T, Williams ESCP, Tremblay MJ, Bosque A, Planelles V (2018). SAMHD1 Phosphorylation Coordinates the Anti-HIV-1 Response by Diverse Interferons and Tyrosine Kinase Inhibition. mBio, 9(3). (Read full article)
    10. Bosque A, Nilson KA, Macedo AB, Spivak AM, Archin NM, Van Wagoner RM, Martins LJ, Novis CL, Szaniawski MA, Ireland CM, Margolis DM, Price DH, Planelles V (2016). Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation. Cell Rep, 18(5), 1324-1334. (Read full article)
    11. Larson EC, Pond CD, Szaniawski MA, Martins LJ, Planelles V, Barrows LR (2016). Macrophage Cell Coinfected with HIV-1 and H37Ra. AIDS Res Hum Retroviruses, 32(12), 1171-1172. (Read full article)
    12. Ramirez PW, DePaula-Silva AB, Szaniawski M, Barker E, Bosque A, Planelles V (2015). HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins. Retrovirology, 12, 65. (Read full article)

    Review

    1. Szaniawski MA, Spivak AM (2020). Senotherapeutics and HIV-1 Persistence. [Review]. Curr HIV/AIDS Rep, 17(3), 219-225. (Read full article)
    2. Szaniawski MA, Spivak AM (2019). Senotherapeutics for HIV and aging. [Review]. Curr Opin HIV AIDS, 15(2), 83-93. (Read full article)
    3. Rodrguez-Mora S, Spivak AM, Szaniawski MA, Lpez-Huertas MR, Alcam J, Planelles V, Coiras M (2019). Tyrosine Kinase Inhibition: a New Perspective in the Fight against HIV. [Review]. Curr HIV/AIDS Rep, 16(5), 414-422. (Read full article)

Schedule Online